Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

The Lancet Rheumatology, 2022
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study

Clark K., Csomor E., Campochiaro C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasmaInterstitial Fluid (skin blisters)

Molecular Metabolism, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism

Ho M., Zhang C., Moon I. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPatient StratificationPlasma

Journal of Neuroendocrinology, 2022
Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors

Thiis‐Evensen E., Kjellman M., Knigge U. et al.

Olink Target 96OncologyPatient StratificationPlasma

International Journal of Cardiology, 2022
Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)

de Lange I., Petersen T., de Bakker M. et al.

Olink Target 96CVDPatient StratificationPlasma

Molecular Psychiatry, 2022
Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study

Sandberg J., Hansson C., Göteson A. et al.

Olink Target 96NeurologyPatient StratificationPlasma

British Journal of Haematology, 2022
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease

Pratta M., Paczesny S., Socie G. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Annals of Oncology, 2022
Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Bessede A., Marabelle A., Guégan J. et al.

OncologyImmunotherapyPatient Stratification

Osteoporosis International, 2022
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial

Sköld C., Kultima K., Freyhult E. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologySerum

PLOS ONE, 2022
Genetically regulated gene expression and proteins revealed discordant effects

Pott J., Garcia T., Hauck S. et al.

Olink Target 96CVDPathophysiologyTechnical EvaluationPlasma

European Journal of Heart Failure, 2022
Distinct pathophysiological pathways in women and men with heart failure

Ravera A., Santema B., de Boer R. et al.

Olink Target 96CVDPathophysiologyPlasma

Scientific Reports, 2022
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction

Girerd N., Cleland J., Anker S. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Allergy, 2022
T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19

Taeschler P., Adamo S., Deng Y. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Nature Communications, 2022
Genetic analyses identify pleiotropy and causality for blood proteins and highlight Wnt/β-catenin signalling in migraine

Tanha H., Nyholt D., Nyholt D.,

Olink Target 96NeurologyPathophysiologyPlasma

Clinical and Translational Medicine, 2022
Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS

García‐Hidalgo M., González J., Benítez I. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

The Journal of Infectious Diseases, 2022
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy

Kolossváry M., deFilippi C., Lu M. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma

Cell Reports Medicine, 2022
TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies

van der Ploeg K., Kirosingh A., Mori D. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

American Journal of Respiratory Cell and Molecular Biology, 2022
Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform

Mickael C., Kheyfets V., Langouët-Astrié C. et al.

Olink Target 96CVDPatient StratificationPlasma

Frontiers in Aging Neuroscience, 2022
The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the AppNL–G–F Model of Alzheimer’s Disease

Nieraad H., de Bruin N., Arne O. et al.

Olink Target 96 MouseNeurologyPathophysiologySerumCSF

Experimental Dermatology, 2022
Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris

Koschitzky M., Navrazhina K., Garshick M. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSerum

Translational Neurodegeneration, 2022
Advances in the development of new biomarkers for Alzheimer’s disease

Klyucherev T., Olszewski P., Shalimova A. et al.

NeurologyReview/editorial

3478 publications